Liege, Belgium, 12 October 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces positive results from preclinical studies demonstrating the efficacy of Estetrol in wound healing. Estetrol (E4) is a naturally occurring estrogen produced by the human fetus during pregnancy, which can be synthesized from plant source. Beyond Women’s health, Mithra is also exploring Estetrol’s potential in other areas of application, in particular in pediatric neuroprotection and wound healing.